MedTech News
.................... by Andrew Celentano
New tool launches to support women through post-loss journey
https://med-techinsights.com/2026/04/22/new-tool-launches-to-support-women-through-post-loss-journey/
Orchestra BioMed wins FDA breakthrough nod for pacemaker in hypertension
Orchestra BioMed (Nasdaq:OBIO) announced today that it received a second FDA breakthrough device designation for its AVIM therapy.
Targeted ‘biological missile’ blocks leukemia growth while sparing healthy tissue
New research out of VCU Massey Comprehensive Cancer Center has uncovered a targeted cancer therapy that significantly prevents leukemia progression, improves survival rates and minimizes damage to surrounding healthy tissue.
A single swab paves the way for simplified tuberculosis diagnosis
Led by researchers from Heidelberg Faculty of Medicine at Heidelberg University and the University of California, San Francisco (U.S.), an international team has evaluated a novel approach for the diagnosis of tuberculosis.
New AI-powered robotic system performs heart ultrasounds without guidance
A Concordia-led team of researchers has developed a new AI-driven robotic system that can perform cardiac ultrasound scans autonomously. The researchers say this approach could expand access to cardiac imaging in remote or underserved areas, reduce operator fatigue, and standardize scan quality. The work is published in the journal IEEE Transactions on Medical Robotics and Bionics.
Scientists discover new way to make drug-resistant cancer treatable again
A research team led by Director Myung Kyungjae at the Center for Genomic Integrity within the Institute for Basic Science (IBS), in collaboration with Lee Joo-Yong (Chungnam University) has now uncovered a new strategy to overcome this resistance. T
Capitan Orthopedics, Inc. Announces Breakthrough Device Designation for its SupraSpacer™ Implant
GRAND RAPIDS, Mich., April 30, 2026 /PRNewswire/ — Capitan Orthopedics, Inc. (https://capitanortho.com/) announced today that it has been granted Breakthrough Device Designation from the U.S. Food & Drug Administration (FDA) for its SupraSpacerTM implant.
Theradaptive Secures FDA Approval to Advance OASIS Trial to Pivotal Study Evaluating OsteoAdapt® SP in Spinal Fusion
FDA authorization marks critical milestone enabling advancement of next-generation bone regeneration therapy for patients with degenerative spinal diseases